Clinical Trial 46263

Pinellas Park, FL 33782


Summary:

 A randomized, double-blind, placebo-controlled trial of adjunctive troriluzole in OCD as an adjunct therapy on subjects with OCD who have had inadequate response to their current OCD treatment.  The study is approximately 18 weeks long of which the participant will be on study medication for 10 weeks. Visits to the clinic are required approximately every 2 weeks.



Must have a primary diagnosis of OCD of at least 1 year and be experiencing non-response or inadequate response to their current standard of care medication (SSRI).  Other criteria will be assessed during pre-screening.


Qualified Participants May Receive:

All study medications, examinations and laboratory testing is provided.  A stipend is provided for transportation and time.


Available At:

DMI Research
6699 90th Ave. N.
Pinellas Park, FL 33782
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.